Cavusoglu, Y. Et Al. 2009. Both levosimendan and dobutamine are equally effective in improving LV systolic functions in heart failure patients receiving beta blocker therapy: a radionuclide ventriculographic study. EUROPEAN HEART JOURNAL , vol.30 , 295.

Cavusoglu, Y., Beyaztas, A., Entok, E., Tek, M., Uslu, I., Demirustu, C., ... Birdane, A.(2009). Both levosimendan and dobutamine are equally effective in improving LV systolic functions in heart failure patients receiving beta blocker therapy: a radionuclide ventriculographic study. EUROPEAN HEART JOURNAL , vol.30, 295.

Cavusoglu, Y. Et Al. "Both levosimendan and dobutamine are equally effective in improving LV systolic functions in heart failure patients receiving beta blocker therapy: a radionuclide ventriculographic study," EUROPEAN HEART JOURNAL , vol.30, 295, 2009

Cavusoglu, Y. Et Al. "Both levosimendan and dobutamine are equally effective in improving LV systolic functions in heart failure patients receiving beta blocker therapy: a radionuclide ventriculographic study." EUROPEAN HEART JOURNAL , vol.30, pp.295, 2009

Cavusoglu, Y. Et Al. (2009) . "Both levosimendan and dobutamine are equally effective in improving LV systolic functions in heart failure patients receiving beta blocker therapy: a radionuclide ventriculographic study." EUROPEAN HEART JOURNAL , vol.30, p.295.

@article{article, author={Y. Cavusoglu Et Al. }, title={Both levosimendan and dobutamine are equally effective in improving LV systolic functions in heart failure patients receiving beta blocker therapy: a radionuclide ventriculographic study}, journal={EUROPEAN HEART JOURNAL}, year=2009, pages={295} }